Not really. The failure of NO doesn’t have any influence on whether ATX’s product works or not. They are unrelated.
In fact it shows the fraught path ahead as the inhaled NO showed promise in the Phase II study but failed at the final hurdle.
Not really. The failure of NO doesn’t have any influence on...
Add ATX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.0¢ |
Change
-0.001(0.83%) |
Mkt cap ! $16.02M | |||
| Open | High | Low | Value | Volume |
| 5.9¢ | 6.1¢ | 5.9¢ | $14.26K | 239.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 52362 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.1¢ | 106202 | 1 |
View Market Depth
| Last trade - 11.23am 17/05/2024 (20 minute delay) ? |
|
|||||
|
Last
6.1¢ |
Change
-0.001 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 6.0¢ | 6.1¢ | 5.9¢ | 184327 | ||
| Last updated 11.23am 17/05/2024 ? | |||||
| ATX (ASX) Chart |